Search

Gene therapy is happening today and cell therapy may soon follow, according to Allen C. Ho, MD. Dr. Ho, professor of ophthalmology, Thomas Jefferson University, and director of retina research, [...]

Faculty and Disclosure Statements Moderator: Allen C. Ho, MD Professor of Ophthalmology Wills Eye Hospital Thomas Jefferson University Philadelphia, Pennsylvania Dr. Ho has disclosed the fallowing financial interests and/or relationships: [...]

Reviewed by Allen C. Ho, MD Miami -- Results from a preclinical tumor model indicate that anti-angiogenic therapy may offer a useful new approach for the treatment of retinoblastoma, said [...]

Reviewed by Allen C. Ho, MD Miami -- The understanding of angiogenesis and its role in the prevention of vision loss was the basis for the first angiogenesis meeting held [...]

Reviewed by Allen C. Ho, MD Sydney -- Smoking is the principal known, preventable risk factor associated with any form of age-related macular degeneration (AMD), according to analyses of combined [...]

Reviewed by Allen C. Ho, MD The management of refractory and complex glaucoma is a challenging and often humbling undertaking. These difficult-to-treat glaucomas include neovascular, traumatic, uveitic, secondary angle closure, [...]

Reviewed by Allen C. Ho, MD Salt Lake City -- Researchers working with an animal model of retinal degenerative disease have demonstrated that a human-derived, extended-life retinal pigment epithelial (RPE) [...]

Reviewed by Allen C. Ho, MD Atlanta -- Research studies are focusing on ways to delay and prevent progression of diabetic retinopathy with both systemic medications and local therapies, noted [...]

Reviewed by Allen C. Ho, MD DETROIT--Electrical stimulation of the visual cortex is not a new idea--it was first proposed in 1967, and the first cortical stimulation device was implanted [...]

Reviewed by Allen C. Ho, MD Mexico City--Vitrectomy may help patients with pars planitis associated with persistent cystoid macular edema (CME). In a study of the effect of surgery in [...]

Reviewed by Allen C. Ho, MD Age-related macular degeneration (AMD) continues to dominate most of the human and financial resources in the retina subspecialty, as researchers are beginning to make [...]

Reviewed by Allen C. Ho, MD Philadelphia-Can lasers be used to reduce drusen and improve visual function in patients with choroidal neovascularization (CNV)? This is the question under study in [...]

Reviewed by Allen C. Ho, MD PHILADELPHIA--The Macular Photocoagulation Study (MPS) demonstrated the value of treating all categories of eligible neovascular lesions associated with age-related macular degeneration (ARMD) or ocular [...]

Philadelphia-The Complications of Age-Related Macular Degeneration Prevention Trial (CAPT) will look at benefits and risks of argon laser photocoagulation in the treatment of drusen, said Allen C. Ho, MD, principal [...]

2024 JAN 13 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in retinal detachment. According to news reporting from [...]

The treatment option can have a positive impact on quality of life for patients. MCO-010 is a novel adeno-associated virus (AAV2)-delivered optogenetic gene therapy designed to treat severe vision loss [...]

2023 MAR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A new study on macular edema is now available. According to news reporting originating [...]

ANTI-VASCULAR ENDOTHELIAL growth factor (VEGF) treatment has undoubtedly revolutionized how ophthalmologists manage patients with wet age-related macular degeneration (AMD). Unfortunately, after more than a decade of the current anti-VEGF monotherapy [...]

Rex-314 subretinal gene therapy (REGENXBIO Inc) is being tested in the first pivotal gene therapy trial for exudative age-related macular degeneration (AMD). Interim results indicate the treatment is generally well [...]

Minimally invasive, sutureless, 25-gauge vitrectomy has been an option for only a few years but appears to be gaining converts, although with widespread acknowledgment that the system has limitations when [...]

AS THE CALENDAR turns to November, we continue to sift through a mountain of information from a busy ophthalmic conference season that recently wrapped up with the American Academy of [...]

Microincision vitrectomy surgery (MIVS) is changing the way that vitreoretinal specialists operate. As with any new technology, MIVS has a number of significant advantages, as well as a few new [...]

Therapies for the management of age-related macular degeneration (AMD) have progressed rapidly in recent years. Ophthalmology Times convened a panel of cutting-edge retinal specialists from across the United States to [...]

Editor's Note: This Ophthalmology Times roundtable discussion was moderated by Carmen A. Puliafito, MD, MBA, of the Bascom Palmer Eye Institute, Miami. Participants in the roundtable were Allen C. Ho, [...]

For more than 10 years, it has been inevitable at every meeting that a colleague will nudge me and ask in hushed tones and quivering whispers about performing retina surgery [...]

The introduction of the Grieshaber Revolution DSP (Alcon) line of disposable intraocular instruments represents a true innovation in the evolution of vitreoretinal surgery, according to retinal specialists Peter Kaiser, MD, [...]

Editor's Note: Dennis M. Robertson, MD, was one of the first to describe retinal arterial macroaneurysm in 1973 in the Transactions of the American Academy of Ophthalmology and Otolaryngology. He [...]

Editor's note: To what extent do we evaluate the elderly, hypertensive patient or the healthy young patient who presents with central retinal vein occlusion? Retinal surgeon Jeffrey Lipkowitz, MD, and [...]

I recently ran a 5K road race, and the race marshal was Louis W. Sullivan, MD, former U.S. Secretary of Health and Human Services from 1989 to 1993. Proceeds from [...]

High myopia (HM) is defined as a myopic refractive error of more than 6 D associated with degenerative posterior and peripheral fundus changes. Due to progressive scleral stretching and vitreous [...]

The management of diffuse clinically significant diabetic macular edema (CSDME) refractory to conventional laser treatment is a complex and often frustrating part of daily clinical practice. Focal CSDME from discrete, [...]

Vitreoretinal surgeons are benefiting from upgrades to the Accurus Surgical System (Alcon Laboratories). The new model features fourth-generation software (XS4), dual dynamic drive (3D) technology that maximizes efficiency, and advanced [...]

Editor's Note: In the absence of other identifiable causes, vision loss in HIV patients may be due to ischemic maculopathy, and that diagnosis should be investigated with fluorescein angiography. The [...]

Thick submacular hemorrhage (SMH) in patients with age-related macular degeneration (AMD) typically presents suddenly, with dramatic loss of central vision. The natural history of untreated SMH is poor. Proposed mechanisms [...]

Angiogenesis is a hot topic in medicine these days. It should also be a hot topic in ophthalmology, particularly for retinal specialists. One merely needs to look at the sight-threatening [...]

Editor's Note: Each year in the United States approximately 70 newly trained vitreoretinal surgeons embark upon their own careers. With an expanding elderly population and a host of vitreoretinal conditions [...]

On July 8, 2013, CMS released the proposed Medicare Physician Fee Schedule (MPFS) for 2014. As currently proposed, the 2014 MPFS provides an overall decrease in physician payment rates of [...]

Since the advent of modern vitreoretinal surgery, most advances in instrumentation have been evolutionary in nature. New technology, however, can occasionally revolutionize how we treat patients. For example, the invention [...]

Editor's Note: Fortunately, massive suprachoroidal hemorrhage is an uncommon event; unfortunately, it is often associated with ocular surgery and it carries a grim visual prognosis. Jose Garcia-Arumi, MD, shares his [...]

Editor's note: In this article, Timothy G. Murray, MD, of the University of Miami Bascom Palmer Eye Institute cogently summarizes the multidisciplinary advances in the treatment of retinoblastoma. He describes [...]

Editor's Note: With this trailblazing program, the Foundation of the American Academy of Ophthalmology and the federal government aim to reduce diabetic blindness in our Medicare patient population. Reducing barriers [...]

A temporary shortage of Adato SIL-OL 5000 silicone oil (Bausch & Lomb) should be alleviated soon, following completion of FDA site inspections of a new facility producing the raw material. [...]

Editor's Note: Dr. Maguire brings us up to date on the evaluation of patients with 'atypical' retinal venous occlusive disease. Clearly, the multitude of abnormalities of the coagulation cascade should [...]

Editor's Note: Since retina surgeons Paul Tornambe, MD, and Vivian Kim, MD, presented information on indocyanine green (ICG) use in vitreoretinal surgery at the 1999 American Academy of Ophthalmology (AAO) [...]

FORT WORTH, TX--Patient recruitment is ongoing in two multicenter, double-masked, placebo-controlled clinical trials evaluating the angiostatic steroid anecortave acetate (Alcon Laboratories) in patients with subfoveal choroidal neovascularization (CNV) secondary to [...]

One of the greatest surgical challenges for vitreoretinal surgeons involves the delamination of adherent tissue to underlying retina. A typical scenario is the attachment of complex diabetic fibrovascular membranes to [...]

Editor's Note: 'Should I be taking lutein?' is a very common question faced when counseling patients with age-related macular degeneration. Thomas A. Ciulla, MD, summarizes his own work and the [...]

Transpupillary thermotherapy (TTT) is a subthreshold laser photocoagulation technique that can result in closure of choroidal neovascularization (CNV) with relative sparing of the neurosensory retina compared with conventional laser photocoagulation [...]

Editor's Note: Since 1996, vitreoretinal surgeons have become comfortable with Vitrasert (Bausch & Lomb) as an intravitreal delivery device to treat cytomegalovirus (CMV) retinitis. Although the frequency with which I [...]